MDXG
MiMedx Group IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$539.18M
P/E Ratio
18.10
EPS
$0.20
Beta
1.46
52W High
$7.99
52W Low
$3.03
50-Day MA
$3.75
200-Day MA
$5.80
Dividend Yield
—
Profit Margin
7.88%
Forward P/E
19.53
PEG Ratio
2.88
About MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
Fundamentals
| Revenue (TTM) | $389.42M |
| Gross Profit (TTM) | $315.59M |
| EBITDA | $52.88M |
| Operating Margin | -27.20% |
| Return on Equity | 13.80% |
| Return on Assets | 8.55% |
| Revenue/Share (TTM) | $2.63 |
| Book Value | $1.73 |
| Price-to-Book | 2.22 |
| Price-to-Sales (TTM) | 1.39 |
| EV/Revenue | 1.021 |
| EV/EBITDA | 7.48 |
| Quarterly Earnings Growth (YoY) | 99.50% |
| Quarterly Revenue Growth (YoY) | -33.10% |
| Shares Outstanding | $148.95M |
| Float | $117.61M |
| % Insiders | 1.94% |
| % Institutions | 77.00% |
Historical Volatility
HV 10-Day
35.63%
HV 20-Day
64.72%
HV 30-Day
66.96%
HV 60-Day
52.76%
HV Rank
97.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.50 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026